- TLDR Biotech
- Archive
- Page -54
The Latest Biotech & Pharma Updates
Biotech & Pharma Updates | August 13 - 14, 2025
🧬 Eli Lilly's $1.3B Superluminal partnership to keep obesity pipeline spry, Trump delays pharma tariffs (but boosts domestic manufacturing), Eli Lilly expands self-pay access to Zepbound via Goodpath partnership, Evotec and TriLink layoffs, Schrödinger cuts investigational CDC7 blocker after two patient deaths
Biotech & Pharma Updates | August 12 - 13, 2025
🧬 Sarepta touts new DMD safety data (no ambulatory deaths), Vor's Sjögren's syndrome disease bet hits late stage trial success in China, Hatteras Venture Partners news $200M biotech/healthtech fund, HopeAI's partners with Mayo Clinical on AI-powered trial design, Treg takes an L as Abata Tx shutters, Generation Bio cuts 90% of staff
Biotech & Pharma Updates | August 11 - 12, 2025
🧬 Summit skips quarterly call as AstraZeneca deal rumors fly, Bayer + Kumquat Biosciences' up to $1.3B KRAS G12D inhibitor deal, Eli Lilly + UK gov launch obesity care access initiative, Insmed scores FDA approval for bronchiectasis therapy, FDA may deny renewed authorization for Pfizer's pediatric COVID vaccine
